title: Interaction of colicins with bacterial cells. IV. Immunity breakdown studied with colicins Ia and Ib.
abstract: Colicinogenic cells are immune to the lethal effect of the colicin which they produce. In the presence of very high concentrations of colicin, however, colicinogenic cells are no longer immune to the homologous colicin. This phenomenon, immunity breakdown, was studied with colicins Ia and Ib. The biochemical effects of colicin Ib on Escherichia coli were studied with a standard noncolicinogenic strain. At multiplicities of about 10 or higher, colicin Ib inhibited incorporation of leucine into protein and incorporation of (32)P-inorganic phosphate into deoxyribonucleic acid and ribonucleic acid by more than 95%. Under the same conditions, (32)P incorporation into phospholipid and nucleotide fractions was inhibited only partially (about 80 and 60%, respectively). Inhibition of (32)P incorporation into the terminal phosphorus of adenosine triphosphate was also considerably less than that of macromolecular synthesis (50 to 60%). (32)P incorporation into the nonnucleotide organic phosphate fraction was not inhibited. Respiration was not affected. Colicin Ia showed the same biochemical effects as colicin Ib. A mutant of an Ib-colicinogenic E. coli strain selected for resistance to low concentrations of colicin Ia was shown to be resistant to high concentrations of homologous colicin Ib, whereas the parent Ib-colicinogenic strain is sensitive to high concentrations of colicin Ib. This mutant lost its specific receptors for colicin Ib. Moreover, the biochemical effects of high concentrations of colicin Ib on Ib-colicinogenic cells during immunity breakdown were similar to the effects found in sensitive cells exposed to low concentrations of the same colicin. It is concluded that the killing of colicinogenic cells in the presence of high concentrations of homologous colicin is indeed caused by the homologous colicin molecules.
mesh_terms: D000255:Adenosine Triphosphate / Q000096:biosynthesis; D000327:Adsorption; D001426:Bacterial Proteins / Q000096:biosynthesis; D002247:Carbon Isotopes; D003087:Colicins / Q000096:biosynthesis / Q000494:pharmacology*; D004269:DNA, Bacterial / Q000096:biosynthesis; D004926:Escherichia coli / Q000187:drug effects* / Q000378:metabolism; D007930:Leucine / Q000378:metabolism; D008055:Lipids / Q000096:biosynthesis; D009711:Nucleotides / Q000096:biosynthesis; D010710:Phosphates / Q000378:metabolism; D010759:Phosphorus Isotopes; D012329:RNA, Bacterial / Q000096:biosynthesis; D014357:Trypsin / Q000494:pharmacology
chemical_list: D001426:Bacterial Proteins; D002247:Carbon Isotopes; D003087:Colicins; D004269:DNA, Bacterial; D008055:Lipids; D009711:Nucleotides; D010710:Phosphates; D010759:Phosphorus Isotopes; D012329:RNA, Bacterial; D000255:Adenosine Triphosphate; D014357:Trypsin; D007930:Leucine